3 June 2024
Directa Plus plc
("Directa Plus", the "Group" or the "Company")
Notice of AGM
Directa Plus (AIM: DCTA), a leader in the production of pristine graphene nanoplatelets for use in consumer and industrial markets through a unique and patented chemical-free process, announces its Annual General Meeting ("AGM") will be held at 3pm on Thursday, 27 June 2024 at 7th Floor, 50 Broadway,
The Annual Report and Accounts for the financial year ended 31 December 2023 will not be laid before the shareholders at the AGM, due to a delay in finalising the audit process and signing the accounts. The Company intends to announce its results for the year ended 31 December 2024 in June 2024, following which the Company will convene a General Meeting at which the receipt of the Annual Report and Accounts and the reappointment of auditors will be put to shareholders.
Shareholders who wish to attend the AGM should register for the event in advance by contacting directaplus@almastrategic.com.
For further information, please contact:
Directa Plus plc |
+39 02 36714458 |
Giulio Cesareo, CEO |
|
Giorgio Bonfanti, CFO |
|
|
|
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) |
+44 131 220 6939 |
Neil McDonald |
|
Adam Rae |
|
|
|
Singer Capital Markets Securities Limited (Joint Broker) |
+44 20 7496 3069 |
Rick Thompson |
|
Phil Davies |
|
|
|
Alma Strategic Communications (Financial PR Adviser) |
+44 20 3405 0205 |
Justine James |
directaplus@almastrategic.com |
Hannah Campbell |
|
Kinvara Verdon |
|
Notes to Editors
Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.
This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products.
Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+(R)) have multiple applications due to its properties. These G+(R) products can be categorised into various families, with different products being suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo (
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.